NCT01784900终止2 期
Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab. A Randomized Phase II Trial.
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 入组人数
- 26
- 试验地点
- 1
- 主要终点
- Progression Free Survival
研究概览
简要总结
Treatment by association of complete surgical excision of the lesions and intraperitoneal immunotherapy using Catumaxomab for patients with gastric peritoneal carcinomatosis
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •consent form signed
- •Age >= 18
- •Carcinomatosis pre operative known or discivered in intraoperative
- •Patients uin good general condition who may have extent surgery associated to specific inflammatory syndrom of immunotherapy
- •Patients in good general condition
- •Patient insured to social care
- •Inclusion Criteria (intraoperative):
- •Gastric adenocarcinoma with macroscopic peritoneal carcinomatosis (PC) confirmed by extemporaneous histological examination
- •CP extension minimal or moderate (peritoneal index ≤ 12).
- •Resection of the entire macroscopic lesions detectable (primary tumor, lymph nodes and CP). cleaning D2 lymph node (or D1.5).
排除标准
- •Presence of metastasis in reach
- •Previous treatment with a non-humanized monoclonal AC- (mice or rat)
- •Hypersensitivity to any type of antibody.
- •History of cancer within 5 years preceding the entry in the trial other than basal cell skin carcinoma or in situ of the cervix,
- •Patients already included in another clinical trial with experimental molecule
- •Pregnant, or likely to be or breastfeeding, (Women of childbearing potential should have a pregnancy test (blood) negative 15 days before the date of the surgery) Using of a suitable method of contraception for patients of childbearing age during treatment. adequate contraception Methods includeare: an intrauterine device, hormonal contraception, condom use combined with a spermicide
- •Persons deprived of liberty or Trust (including curatorship)
- •Unable to undergo medical test for geographical, social or psychological.
- •Exclusion Criteria (intraoperative):
- •Persistent peritoneal lesions visible to the end of the surgery
- •Resection of the tail of the pancreas or pancreatic break (because no drainage post-op); break pleural (for K cardia)
- •Presence of metastasis in reach during surgery (except for ovarian metastasis
研究组 & 干预措施
Schema B (140µg)
Experimental
- D0 : 20 μg of catumaxomab
- D2 : 40 μg
- D4 : 80 μg
干预措施: Catumaxomab 140µg (Drug)
Schema A (100µg)
Experimental
- D0 : 10 μg of catumaxomab
- D2 : 30 μg
- D4 : 60 μg
干预措施: Catumaxomab 100µg (Drug)
结局指标
主要结局
Progression Free Survival
时间窗: every 3 months for the first two years
次要结局
- Progression Free Survival(every 3 months for the first two years then every 4 months on year 3 then every 6 months on year 4 and 5)
研究者
研究点 (1)
Loading locations...
相似试验
暂停
2 期
Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric CarcinomatosisPeritoneal CarcinomatosisGastric CancerNCT01342653Hospital General Universitario Gregorio Marañon50
招募中
不适用
Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal CarcinomatosisPeritoneal CarcinomatosisGastric CancerNCT04547725National Taiwan University Hospital48
已完成
1 期
Concomitant Intraperitoneal and Systemic Chemotherapy in Patients with Extensive Peritoneal Carcinomatosis of Gastric OriginPeritoneal MetastasesGastric CancerNCT05379790Erasmus Medical Center20
已完成
不适用
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric CancerPeritoneal CarcinomatosisGastric CancerNCT03253939Hospices Civils de Lyon275
招募中
2 期
Perioperative Treatment in Resectable Gastric Cancer with Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): A phase II study (GASPAR)2024-516299-13-00Centre Francois Baclesse68
